Triple-negative breast cancer (TNBC), characterized by the absence or low expression of
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …

Estrogen receptor β (ERβ) is closely related to breast cancer (BC) progression. Traditional
concepts regard ERβ as a tumor suppressor. As studies show the carcinogenic effect of …

Triple-negative breast cancer (TNBC) lacks estrogen receptor (ER) α, but the expression of
estrogen receptors ERβ and G protein-coupled estrogen receptor 1 (GPER-1) is able to …

To identify regulators of triple-negative breast cancer (TNBC), gene expression profiles of
malignant parts of TNBC (mTNBC) and normal adjacent (nadj) parts of the same breasts …

Introduction Tamoxifen, a selective estrogen receptor (ER) modulator, may affect cancer cell
survival through mechanisms other than ER antagonism. In the present study, we tested the …

Breast cancer, a malignant tumor originating from mammary epithelial tissue, is the most
common cancer among women worldwide. Challenges facing the diagnosis and treatment …

Triple Negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression
of estrogen receptor (ER), progesterone receptor, and human epidermal growth factor …

Simple Summary Young women treated for breast cancer may experience early
menopause, which can negatively impact quality of life. The usual treatment for early …

Extracellular RNAs (exRNAs) are present in human serum. It remains unclear to what extent
these circulating exRNAs may reflect human physiologic and disease states. Here, we …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer
characterized by the absence of estrogen receptor alpha, progesterone receptor, and HER2 …